Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1458079

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1458079

Global Smart Inhalers Market Size, Share, Growth Analysis, By Type(Dry powdered inhalers and metered dose inhalers ), By Distribution Channel, By End-Use - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Smart Inhalers Market size was valued at USD 12.22 billion in 2022 and is poised to grow from USD 14.64 billion in 2023 to USD 62.11 billion by 2031, growing at a CAGR of 19.8% during the forecast period (2024-2031).

The treatment of respiratory conditions including asthma and COPD is being revolutionized by the quickly expanding global smart inhalers market, a sector of the healthcare sector. Smart inhalers are medical devices that track and monitor patients' inhaler usage using sensors and Bluetooth technology. Healthcare professionals can use the data that smart inhalers collect to better monitor patient adherence to prescription schedules and modify treatment strategies as necessary. By allowing healthcare practitioners to monitor patient drug usage and make real-time treatment plan adjustments, the industry aims to improve the efficacy and efficiency of respiratory disease therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Inhalers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Inhalers Market Segmental Analysis

Global Smart Inhalers Market is segmented on the basis of type, distribution channel, end-use, and region. By type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By end-use, the market is segmented into hospitals, homecare settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Inhalers Market

Innovations in technology are a major factor propelling the market for smart inhalers. The treatment of respiratory disorders has changed dramatically as a result of the introduction of sophisticated sensors, networking choices, and data analytics tools. Personalized treatment and better patient outcomes are made possible by smart inhalers' ability to gather and communicate data in real-time to healthcare practitioners about medicine usage, inhaler technique, and environmental variables. One digital therapeutics startup, Propeller Health, has created a sensor-based smart inhaler platform. The platform is made up of a sensor that fits onto common inhalers and monitors drug intake. The gathered information is transferred to a smartphone app, which gives patients and medical professionals information and alerts.

Restraints in the Global Smart Inhalers Market

The comparatively expensive price of smart inhalers in comparison to traditional inhalers is one of the market's limitations. Smart inhalers are more expensive because of their sophisticated technology and connection features. Their broad adoption may be constrained by their cost, especially in areas with scarce healthcare resources and affordability issues. For instance, the cost of a smart inhaler might vary from $100 to $300, based on the features and brand. Patients with low incomes or no insurance may find this increased expense to be problematic. Because of this, the market growth of smart inhalers may be hampered in some markets where their adoption is delayed.

Market Trends of the Global Smart Inhalers Market

The incorporation of machine learning (ML) and artificial intelligence (AI) algorithms into inhaler technology is a significant trend in the smart inhalers market. Large datasets gathered from smart inhalers can be analyzed by AI and ML approaches, which can also spot trends and offer predictive insights. This makes it possible for medical professionals to anticipate exacerbations, optimize medicine dosage, and customize treatment regimens. For instance, the digital health startup Cohero Health has created a smart inhaler system that uses ML and AI algorithms. In order to give patients and healthcare professionals individualized recommendations and real-time feedback, the system examines inhaler usage trends, environmental data, and patient-specific information. This trend demonstrates how AI and ML can be used to improve patient outcomes and the management of respiratory diseases.

Product Code: SQMIG35A2315

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Smart Inhalers Market by Type

  • Market Overview
  • Dry powdered inhalers (DPIs) and metered dose inhalers (MDIs)

Global Smart Inhalers Market by Distribution Channel

  • Market Overview
  • Hospital pharmacies
  • retail pharmacies
  • and online pharmacies

Global Smart Inhalers Market by End-Use

  • Market Overview
  • Hospitals
  • homecare settings
  • and others

Global Smart Inhalers Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Teva Pharmaceuticals (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Respironics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Propeller Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vectura Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Opko Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Adherium Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AptarGroup (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cohero Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • H&T Presspart (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cipla (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mundipharma (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glenmark Pharmaceuticals (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chiesi Farmaceutici (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Propeller Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sensirion AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!